Multiple regression analysis of relationship between frontal lobe phosphorus metabolism and clinical symptoms in patients with schizophrenia

Psychiatry Research - Neuroimaging

Volumn 76, Issue 2-3, 1997, Pages 113-122

  Shioiri, Toshiki ^a,b   Someya, Toshiyuki ^a   Murashita, Jun ^a   Kato, Tadafumi ^c   Hamakawa, Hiroshi ^a   Fujii, Kumiko ^a   Inubushi, Toshiro ^a  

^a SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

Brief Psychiatric Rating Scale (BPRS); Frontal lobe; Hypofrontality; Negative symptoms; Phosphorus 31 magnetic resonance spectroscopy (31P MRS); Schizophrenia

Indexed keywords

ADENOSINE TRIPHOSPHATE; CREATINE PHOSPHATE; ESTER; PHOSPHATE; PHOSPHORUS; PHOSPHORUS 31;

ADOLESCENT; ADULT; ARTICLE; BRAIN METABOLISM; CATATONIA; CLINICAL ARTICLE; FEMALE; FRONTAL LOBE; HUMAN; MALE; MOTOR RETARDATION; MULTIPLE REGRESSION; PARANOID SCHIZOPHRENIA; PHOSPHATE METABOLISM; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; RATING SCALE; SCHIZOPHRENIA; SYMPTOMATOLOGY;

ADOLESCENT; ADULT; BRIEF PSYCHIATRIC RATING SCALE; FEMALE; FRONTAL LOBE; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; PHOSPHORUS; REGRESSION ANALYSIS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY;

EID: 0031592281     PISSN: 09254927     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0925-4927(97)00064-4     Document Type: Article

References (51)

1. American Psychiatric Association, 1987. DSM-III-R: Diagnostic and Statistical Manual of Mental Disorders, 3rd rev. ed. American Psychiatric Press, Washington, DC.
2. Andreasen N.C., Rezai K., Aliger R., Swayze V.W., Flaum M., Kirchner P., Cohen G., O'Leary D.S. Hypofrontality in neuroleptic-naive patients and in patients with chronic schizophrenia: assessment with Xenon 133 single-photon emission computed tomography and the Tower of London. Archives of General Psychiatry. 49:1992;943-958.
3. Bachneff S.A. Regional cerebral blood flow in schizophrenia and the local circuit neurons hypothesis. Schizophrenia Bulletin. 22:1996;163-182.
4. Bottomley P.A. The trouble with spectroscopy papers. Radiology. 181:1991;341-350.
5. 13C NMR. Journal of Magnetic Resonance. 59:1984;338-342.
6. Brown J.S. Phosphomonoesters and phosphodiesters in the brains of schizophrenic patients. Archives of General Psychiatry. 49:1992;416-416.
7. Cady, E.B., 1990. Clinical Magnetic Resonance Spectroscopy. Plenum Press, New York.
8. 31Phosphorus magnetic resonance spectroscopy of the temporal lobes in schizophrenia. Biological Psychiatry. 32:1992;26-32.
9. Campbell I.D., Dobson C.M., Williams R.J.P., Xavier A.V. Resolution enhancement of protein PMR spectra using the difference between a broadened and a normal spectrum. Journal of Magnetic Resonance. 11:1973;172-181.
10. Dawson, R.M.C., 1985. Enzymatic pathways of phospholipid metabolism in the nervous system. In: Eichberg, J. (Ed.), Phospholipids in Nervous Tissue. Wiley, New York, pp. 45-78.
11. 31Phosphorus magnetic resonance spectroscopy of the frontal and parietal lobes in chronic schizophrenia. Biological Psychiatry. 36:1994;503-510.
12. Deicken R.F., Merrin E.L., Floyd T.C., Weiner M.W. Correlation between left frontal phospholipid and Wisconsin card sort test performance in schizophrenia. Schizophrenia Research. 14:1995;177-181.
13. Deicken R.F., Fein G., Weiner M.W. Abnormal frontal lobe phosphorus metabolism in bipolar disorder. American Journal of Psychiatry. 152:1995;915-918.
14. 99mTc-hexametazine in unmedicated schizophrenic patients. Biological Psychiatry. 33:1993;487-495.
15. Erecinska M., Silver I.A. ATP and brain function. Journal of Cerebral Blood Flow and Metabolism. 9:1989;2-19.
16. 31P chemical shift imaging. Acta Psychiatrica Scandinavica. 86:1992;455-462.
17. Fukuzako H., Fukuzako T., Takeuchi K., Ohbo Y., Ueyama K., Takigawa M., Fujimoto T. Phosphorus magnetic resonance spectroscopy in schizophrenia: correlation between membrane phospholipid metabolism in the temporal lobe and positive symptoms. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 20:1996;629-640.
18. Gelenberg, A.J., 1983. In: Basuk E.L., Schoonover, S.C., Gelenberg, A.J. (Eds.), The Practitioner Guide to Psychoactive Drugs. Plenum Publishing, New York.
19. George T.P., Spence M.W. Alternations of membrane phospholipid metabolism in patients with schizophrenia assessed by phosphorus magnetic resonance spectroscopy. Archives of General Psychiatry. 53:1996;1065-1066.
20. 31P MRS. Journal of Affective Disorders. 22:1991;185-190.
21. Kato T., Takahashi S., Shioiri T., Inubushi T. Brain phosphorus metabolism in depressive disorders detected by phosphorus-31 magnetic resonance spectroscopy. Journal of Affective Disorders. 26:1992;223-230.
22. 7Li magnetic resonance spectroscopy. Journal of Affective Disorders. 27:1993;53-60.
23. Kato T., Shioiri T., Murashita J., Hamakawa H., Inubushi T., Takahashi S. Lateralized abnormality of high-energy phosphate and bilateral reduction of phosphomonoester measured by phosphorus-31 magnetic resonance spectroscopy of the frontal lobes in schizophrenia. Psychiatry Research: Neuroimaging. 61:1995;151-160.
24. 31P-MRS. Psychological Medicine. 25:1995;557-566.
25. Kawasaki Y., Maeda Y., Sakai N., Nigashima M., Yamaguchi N., Koshimo Y., Hisada K., Suzuki M., Matsuda H. Regional cerebral blood flow in patients with schizophrenia: relevance to symptom structures. Psychiatry Research: Neuroimaging. 67:1996;49-58.
26. Kay S.R., Fiszbein A., Opler L.A. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophrenia Bulletin. 13:1987;261-267.
27. Keshavan M.S., Pettegrew J.W., Panchalingam K.S., Kaplan D., Bozik E. Phosphorus 31 magnetic resonance spectroscopy detects altered brain metabolism before onset of schizophrenia. Archives of General Psychiatry. 48:1991;1112.
28. 31P NMR spectrum of human brain: the determination of the concentrations of phosphodiester components. FEBS Letters. 272:1990;163-165.
29. 11C-glucose positron emission tomography. Psychiatry Research. 21:1987;285-292.
30. Kitamura T., Yuzuriha T., Morita M., Itoh I., Suga R., Nakagawa Y. Oxford version of the BPRS: development and validation of subscales. Psychiatric Diagnosis. 1:1990;107-107.
31. 31P-NMR spectroscopic study. Magnetic Resonance in Medicine. 6:1988;296-299.
32. LaBruzza, A.L., Mendez-Villarrubia, J.M., 1994. Using DSM-IV: A Clinician's Guide to Psychiatric Diagnosis. Jason Aronson, New Jersey.
33. Liddle P.F., Friston K.J., Frith C.D., Hirsch S.R., Jones T., Frackowiak R.S.J. Pattern of cerebral blood flow in schizophrenia. British Journal of Psychiatry. 160:1992;179-186.
34. Lock T., Abou-Saleh M.T., Edwards R.H.T. Psychiatry and the new magnetic resonance era. British Journal of Psychiatry. 157:1990;38-55.
35. Minshew N.J., Pettegrew J.W., Rayton J.R., Panchalingam K. Metabolic alterations in the dorsal prefrontal cortex of autistic patients with normal IQ (abstract). Annals of Neurology. 26:1989;438A.
36. 31P NMR spectrum in vivo. Magnetic Resonance in Medicine. 12:1989;282-289.
37. Overall J.E., Gorham D.R. The brief psychiatric rating scale. Psychological Reports. 10:1962;799-812.
38. 31P nuclear magnetic resonance spectroscopy. Neurology. 35:1985;781-788.
39. 31P nuclear magnetic resonance studies of phosphoglyceride metabolism in developing and degenerating brain: preliminary observations. Journal of Neuropathology and Experimental Neurology. 46:1987;419-430.
40. 31P NMR in normal IQ adult autistics (abstract). Biological Psychiatry. 25:1989;182A-183A.
41. Pettegrew J.W., Keshavan M.S., Panchalingam K., Strychor S., Kaplan D.B., Tretta R.N., Allen M. Alterations in brain high-energy phosphate and membrane phospholipid metabolism in first-episode, drug-naive schizophrenics. Archives of General Psychiatry. 48:1991;563-568.
42. Sauter A., Rubin M. Determination of creatine kinase kinetic parameters in rat brain by NMR magnetization transfer: correlation with brain function. Journal of Biological Chemistry. 268:1993;13166-13171.
43. Schlaepfer T.E., Harris G.J., Tien A.Y., Peng L.W., Lee S., Federman E.B., Chase G.A., Barta P.E., Pearlson G.D. Decreased regional cortical gray matter volume in schizophrenia. American Journal of Psychiatry. 151:1994;842-848.
44. Selemon L.D., Rajkowska G., Goldman-Rakic P.S. Abnormally high neuronal density in the schizophrenic cortex: a morphometric analysis of prefrontal area 9 and occipital area 17. Archives of General Psychiatry. 52:1995;805-818.
45. 31P-MRS-measured phosphomonoester in the frontal region and negative symptoms in schizophrenia. Psychiatry Research: Neuroimaging. 55:1994;223-235.
46. 31P-MRS. Biological Psychiatry. 40:1996;785-793.
47. 31P-MR spectroscopy study. Schizophrenia Research. 13:1994;209-215.
48. Weinberger D.R., Berman K.F., Zec R.F. Physiological dysfunction of dorsolateral prefrontal cortex in schizophrenia. I. Regional cerebral blood flow (rCBF) evidence. Archives of General Psychiatry. 43:1986;114-125.
49. Wible C.G., Shenton M.E., Hokama H., Kikinis R., Jolesz F.A., Metcalf D., McCarley R.W. Prefrontal cortex and schizophrenia: a quantitative magnetic resonance imaging study. Archives of General Psychiatry. 52:1995;279-288.
50. Williamson P., Drost D., Stanley J., Carr T., Morrison S., Merskey H. Localized phosphorus-31 magnetic resonance spectroscopy in chronic schizophrenic patients and normal controls. Archives of General Psychiatry. 48:1991;578.
51. Zemishlany Z., Alexander G.E., Goldman R.G., Mukherjee S., Sackeim H. Cortical blood flow and negative symptoms in schizophrenia. Neurobiology. 33:1996;127-131.